Richardson Debra L
Associate Professor and Section Chief, Division of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, 800 NE 10th St, Oklahoma City, OK 73104, USA.
Gynecol Oncol Rep. 2023 Feb 9;46:101148. doi: 10.1016/j.gore.2023.101148. eCollection 2023 Apr.
Recently, two antibody drug conjugates were FDA approved for the treatment of recurrent gynecologic malignancies. Both of these new agents are associated with ocular toxicity. Ocular toxicity can be prevented and mitigated by utilizing recommended eye care strategies.
最近，两种抗体药物偶联物被美国食品药品监督管理局（FDA）批准用于治疗复发性妇科恶性肿瘤。这两种新药都与眼部毒性有关。通过采用推荐的眼部护理策略，可以预防和减轻眼部毒性。
